BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 19139381)

  • 1. Ventricular phosphodiesterase-5 expression is increased in patients with advanced heart failure and contributes to adverse ventricular remodeling after myocardial infarction in mice.
    Pokreisz P; Vandenwijngaert S; Bito V; Van den Bergh A; Lenaerts I; Busch C; Marsboom G; Gheysens O; Vermeersch P; Biesmans L; Liu X; Gillijns H; Pellens M; Van Lommel A; Buys E; Schoonjans L; Vanhaecke J; Verbeken E; Sipido K; Herijgers P; Bloch KD; Janssens SP
    Circulation; 2009 Jan; 119(3):408-16. PubMed ID: 19139381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased cardiac myocyte PDE5 levels in human and murine pressure overload hypertrophy contribute to adverse LV remodeling.
    Vandenwijngaert S; Pokreisz P; Hermans H; Gillijns H; Pellens M; Bax NA; Coppiello G; Oosterlinck W; Balogh A; Papp Z; Bouten CV; Bartunek J; D'hooge J; Luttun A; Verbeken E; Herregods MC; Herijgers P; Bloch KD; Janssens S
    PLoS One; 2013; 8(3):e58841. PubMed ID: 23527037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Letter by Cingolani et al regarding article, "Ventricular phosphodiesterase-5 expression is increased in patients with advanced heart failure and contributes to adverse ventricular remodeling after myocardial infarction in mice".
    Cingolani OH; Pérez NG; Cingolani HE
    Circulation; 2009 Oct; 120(15):e137; author reply e138. PubMed ID: 19822814
    [No Abstract]   [Full Text] [Related]  

  • 4. Phosphodiesterase-5 Is Elevated in Failing Single Ventricle Myocardium and Affects Cardiomyocyte Remodeling In Vitro.
    Garcia AM; Nakano SJ; Karimpour-Fard A; Nunley K; Blain-Nelson P; Stafford NM; Stauffer BL; Sucharov CC; Miyamoto SD
    Circ Heart Fail; 2018 Sep; 11(9):e004571. PubMed ID: 30354365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial remodeling is controlled by myocyte-targeted gene regulation of phosphodiesterase type 5.
    Zhang M; Takimoto E; Hsu S; Lee DI; Nagayama T; Danner T; Koitabashi N; Barth AS; Bedja D; Gabrielson KL; Wang Y; Kass DA
    J Am Coll Cardiol; 2010 Dec; 56(24):2021-30. PubMed ID: 20970280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction.
    Janssens S; Pokreisz P; Schoonjans L; Pellens M; Vermeersch P; Tjwa M; Jans P; Scherrer-Crosbie M; Picard MH; Szelid Z; Gillijns H; Van de Werf F; Collen D; Bloch KD
    Circ Res; 2004 May; 94(9):1256-62. PubMed ID: 15044322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Right ventricular cyclic nucleotide signaling is decreased in hyperoxia-induced pulmonary hypertension in neonatal mice.
    Heilman RP; Lagoski MB; Lee KJ; Taylor JM; Kim GA; Berkelhamer SK; Steinhorn RH; Farrow KN
    Am J Physiol Heart Circ Physiol; 2015 Jun; 308(12):H1575-82. PubMed ID: 25862831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MCIP1 overexpression suppresses left ventricular remodeling and sustains cardiac function after myocardial infarction.
    van Rooij E; Doevendans PA; Crijns HJ; Heeneman S; Lips DJ; van Bilsen M; Williams RS; Olson EN; Bassel-Duby R; Rothermel BA; De Windt LJ
    Circ Res; 2004 Feb; 94(3):e18-26. PubMed ID: 14739160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein tyrosine phosphatase 1B inactivation limits aging-associated heart failure in mice.
    Besnier M; Coquerel D; Favre J; Dumesnil A; Guerrot D; Remy-Jouet I; Mulder P; Djerada Z; Tamion F; Richard V; Ouvrard-Pascaud A
    Am J Physiol Heart Circ Physiol; 2018 Jun; 314(6):H1279-H1288. PubMed ID: 29569957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice.
    Shiomi T; Tsutsui H; Matsusaka H; Murakami K; Hayashidani S; Ikeuchi M; Wen J; Kubota T; Utsumi H; Takeshita A
    Circulation; 2004 Feb; 109(4):544-9. PubMed ID: 14744974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress regulates left ventricular PDE5 expression in the failing heart.
    Lu Z; Xu X; Hu X; Lee S; Traverse JH; Zhu G; Fassett J; Tao Y; Zhang P; dos Remedios C; Pritzker M; Hall JL; Garry DJ; Chen Y
    Circulation; 2010 Apr; 121(13):1474-83. PubMed ID: 20308615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenoviral short hairpin RNA therapy targeting phosphodiesterase 5a relieves cardiac remodeling and dysfunction following myocardial infarction.
    Li L; Haider HKh; Wang L; Lu G; Ashraf M
    Am J Physiol Heart Circ Physiol; 2012 May; 302(10):H2112-21. PubMed ID: 22447941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice.
    Scherrer-Crosbie M; Ullrich R; Bloch KD; Nakajima H; Nasseri B; Aretz HT; Lindsey ML; Vançon AC; Huang PL; Lee RT; Zapol WM; Picard MH
    Circulation; 2001 Sep; 104(11):1286-91. PubMed ID: 11551881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological cardiac hypertrophy alters intracellular targeting of phosphodiesterase type 5 from nitric oxide synthase-3 to natriuretic peptide signaling.
    Zhang M; Takimoto E; Lee DI; Santos CX; Nakamura T; Hsu S; Jiang A; Nagayama T; Bedja D; Yuan Y; Eaton P; Shah AM; Kass DA
    Circulation; 2012 Aug; 126(8):942-51. PubMed ID: 22829024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction.
    Doerries C; Grote K; Hilfiker-Kleiner D; Luchtefeld M; Schaefer A; Holland SM; Sorrentino S; Manes C; Schieffer B; Drexler H; Landmesser U
    Circ Res; 2007 Mar; 100(6):894-903. PubMed ID: 17332431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial connective tissue growth factor (CCN2/CTGF) attenuates left ventricular remodeling after myocardial infarction.
    Gravning J; Ørn S; Kaasbøll OJ; Martinov VN; Manhenke C; Dickstein K; Edvardsen T; Attramadal H; Ahmed MS
    PLoS One; 2012; 7(12):e52120. PubMed ID: 23284892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac-specific overexpression of diacylglycerol kinase zeta attenuates left ventricular remodeling and improves survival after myocardial infarction.
    Niizeki T; Takeishi Y; Arimoto T; Takahashi H; Shishido T; Koyama Y; Goto K; Walsh RA; Kubota I
    Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H1105-12. PubMed ID: 17071729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The α2-isoform of the Na
    Cellini A; Höfler D; Arias-Loza PA; Bandleon S; Langsenlehner T; Kohlhaas M; Maack C; Bauer WR; Eder-Negrin P
    Am J Physiol Heart Circ Physiol; 2021 Oct; 321(4):H650-H662. PubMed ID: 34448639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of A kinase interacting protein 1 attenuates myocardial ischaemia/reperfusion injury but does not influence heart failure development.
    Booij HG; Yu H; De Boer RA; van de Kolk CW; van de Sluis B; Van Deursen JM; Van Gilst WH; Silljé HH; Westenbrink BD
    Cardiovasc Res; 2016 Aug; 111(3):217-26. PubMed ID: 27302402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.